The controllable assembly of three-dimensional (3D) nano materials from one-dimensional (1D) precursor has always been one of the difficulties in nano material synthesis. Here, we use a gentle hydrolysis of...
The polyhedral Pd nanocrystals are synthesized by a facile conventional hydrothermal method, in which the cetyltrimethylammonium bromide, Fe3+ and formaldehyde are designed as structural orientation, etching and reduction agents, respectively. The crystal and morphological characteristics show that the crystal facets of (111) and (220) planes are exposed on the surface of face‐centered cubic crystal structure of Pd polyhedron. Electrochemical analyses indicate that the polyhedral Pd/XC‐72 catalyst shows the highest electrochemically active surface area (57.6 m2 g−1), similar half‐wave potential and diffusion‐limiting current density (‐4.79 mA cm−2) with state‐of‐the‐art commercial Pd/C in alkaline electrolytes. The excellent electrocatalytic activity supports a four‐electron‐transfer pathway and smaller Tafel slope (67.2 mV dec−1) reveals a higher intrinsic activity for ORR. Additionally, the polyhedral Pd/XC‐72 catalyst also exhibits much better methanol tolerance crossover effects and long‐term stability than commercial Pd/C. All these excellent electrocatalytic performances are considered to be the coaction of the exposed high surface energy facets and more of active sites on the polyhedral crystals surface, which could significantly improve the adsorption and activation energies with oxygenated intermediates in alkaline solution. This work provides a new prospect in designing high active, non‐easy tolerance and more stable Pd‐based catalyst in alkaline fuel cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.